Challenges posed by COVID‐19 in cancer patients: A narrative review
Abstract A novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), was identified as the causative agent of coronavirus disease 2019 (COVID‐19). In early 2020, the World Health Organization declared COVID‐19 the sixth public health emergency of international concern. The...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.4519 |
| _version_ | 1819283766977232896 |
|---|---|
| author | Zeinab Mohseni Afshar Rezvan Hosseinzadeh Mohammad Barary Soheil Ebrahimpour Amirmasoud Alijanpour Babak Sayad Dariush Hosseinzadeh Seyed Rouhollah Miri Terence T. Sio Mark J. M. Sullman Kristin Carson‐Chahhoud Arefeh Babazadeh |
| author_facet | Zeinab Mohseni Afshar Rezvan Hosseinzadeh Mohammad Barary Soheil Ebrahimpour Amirmasoud Alijanpour Babak Sayad Dariush Hosseinzadeh Seyed Rouhollah Miri Terence T. Sio Mark J. M. Sullman Kristin Carson‐Chahhoud Arefeh Babazadeh |
| author_sort | Zeinab Mohseni Afshar |
| collection | DOAJ |
| description | Abstract A novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), was identified as the causative agent of coronavirus disease 2019 (COVID‐19). In early 2020, the World Health Organization declared COVID‐19 the sixth public health emergency of international concern. The COVID‐19 pandemic has substantially affected many groups within the general population, but particularly those with extant clinical conditions, such as having or being treated for cancer. Cancer patients are at a higher risk of developing severe COVID‐19 since the malignancy and chemotherapy may negatively affect the immune system, and their immunocompromised condition also increases the risk of infection. Substantial international efforts are currently underway to develop specific methods for diagnosing and treating COVID‐19. However, cancer patients’ risk profiles, management, and outcomes are not well understood. Thus, the main objective of this review is to discuss the relevant evidence to understand the prognosis of COVID‐19 infections in cancer patients more clearly, as well as helping to improve the clinical management of these patients. |
| first_indexed | 2024-12-24T01:36:42Z |
| format | Article |
| id | doaj.art-e5028c772c0e402eb433150c90b0b15d |
| institution | Directory Open Access Journal |
| issn | 2045-7634 |
| language | English |
| last_indexed | 2024-12-24T01:36:42Z |
| publishDate | 2022-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj.art-e5028c772c0e402eb433150c90b0b15d2022-12-21T17:22:10ZengWileyCancer Medicine2045-76342022-02-011141119113510.1002/cam4.4519Challenges posed by COVID‐19 in cancer patients: A narrative reviewZeinab Mohseni Afshar0Rezvan Hosseinzadeh1Mohammad Barary2Soheil Ebrahimpour3Amirmasoud Alijanpour4Babak Sayad5Dariush Hosseinzadeh6Seyed Rouhollah Miri7Terence T. Sio8Mark J. M. Sullman9Kristin Carson‐Chahhoud10Arefeh Babazadeh11Clinical Research Development Center Imam Reza Hospital Kermanshah University of Medical Sciences Kermanshah IranStudent Research Committee Babol University of Medical Sciences Babol IranStudent Research Committee Babol University of Medical Sciences Babol IranInfectious Diseases and Tropical Medicine Research Center Health Research Institute Babol University of Medical Sciences Babol IranFaculty of Medicine Semmelweis University Üllői út 26 Budapest HungaryClinical Research Development Center Imam Reza Hospital Kermanshah University of Medical Sciences Kermanshah IranO. O. Bogomolets National Medical University Kyiv UkraineCancer Research Center Cancer Institute of Iran Tehran University of Medical Science Tehran IranDepartment of Radiation Oncology Mayo Clinic Phoenix Arizona USADepartment of Social Sciences University of Nicosia Nicosia CyprusAustralian Centre for Precision Health University of South Australia Adelaide AustraliaInfectious Diseases and Tropical Medicine Research Center Health Research Institute Babol University of Medical Sciences Babol IranAbstract A novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), was identified as the causative agent of coronavirus disease 2019 (COVID‐19). In early 2020, the World Health Organization declared COVID‐19 the sixth public health emergency of international concern. The COVID‐19 pandemic has substantially affected many groups within the general population, but particularly those with extant clinical conditions, such as having or being treated for cancer. Cancer patients are at a higher risk of developing severe COVID‐19 since the malignancy and chemotherapy may negatively affect the immune system, and their immunocompromised condition also increases the risk of infection. Substantial international efforts are currently underway to develop specific methods for diagnosing and treating COVID‐19. However, cancer patients’ risk profiles, management, and outcomes are not well understood. Thus, the main objective of this review is to discuss the relevant evidence to understand the prognosis of COVID‐19 infections in cancer patients more clearly, as well as helping to improve the clinical management of these patients.https://doi.org/10.1002/cam4.4519cancerCOVID‐19immunodeficiencySARS‐CoV‐2 |
| spellingShingle | Zeinab Mohseni Afshar Rezvan Hosseinzadeh Mohammad Barary Soheil Ebrahimpour Amirmasoud Alijanpour Babak Sayad Dariush Hosseinzadeh Seyed Rouhollah Miri Terence T. Sio Mark J. M. Sullman Kristin Carson‐Chahhoud Arefeh Babazadeh Challenges posed by COVID‐19 in cancer patients: A narrative review Cancer Medicine cancer COVID‐19 immunodeficiency SARS‐CoV‐2 |
| title | Challenges posed by COVID‐19 in cancer patients: A narrative review |
| title_full | Challenges posed by COVID‐19 in cancer patients: A narrative review |
| title_fullStr | Challenges posed by COVID‐19 in cancer patients: A narrative review |
| title_full_unstemmed | Challenges posed by COVID‐19 in cancer patients: A narrative review |
| title_short | Challenges posed by COVID‐19 in cancer patients: A narrative review |
| title_sort | challenges posed by covid 19 in cancer patients a narrative review |
| topic | cancer COVID‐19 immunodeficiency SARS‐CoV‐2 |
| url | https://doi.org/10.1002/cam4.4519 |
| work_keys_str_mv | AT zeinabmohseniafshar challengesposedbycovid19incancerpatientsanarrativereview AT rezvanhosseinzadeh challengesposedbycovid19incancerpatientsanarrativereview AT mohammadbarary challengesposedbycovid19incancerpatientsanarrativereview AT soheilebrahimpour challengesposedbycovid19incancerpatientsanarrativereview AT amirmasoudalijanpour challengesposedbycovid19incancerpatientsanarrativereview AT babaksayad challengesposedbycovid19incancerpatientsanarrativereview AT dariushhosseinzadeh challengesposedbycovid19incancerpatientsanarrativereview AT seyedrouhollahmiri challengesposedbycovid19incancerpatientsanarrativereview AT terencetsio challengesposedbycovid19incancerpatientsanarrativereview AT markjmsullman challengesposedbycovid19incancerpatientsanarrativereview AT kristincarsonchahhoud challengesposedbycovid19incancerpatientsanarrativereview AT arefehbabazadeh challengesposedbycovid19incancerpatientsanarrativereview |